FrancophonIA/ELRC3.0 huggingface dataset:
English: Patients usually experience an improvement in lung function within 16-17 minutes of inhaling Revinty Ellipta.
Danish: Patienter oplever normalt en forbedring af lungefunktionen i løbet af 16-17 minutter efter inhalation af Revinty Ellipta.
English: If your symptoms (breathlessness, wheezing, cough) do not improve or get worse, or if you are using your quick-acting inhaler more often contact your doctor as soon as possible.
Danish: Hvis dine symptomer (åndenød, hvæsende vejrtrækning, hoste) ikke aftager, eller hvis de bliver værre, eller hvis du oftere inhalerer et lægemiddel med hurtig virkning, skal du kontakte lægen så hurtigt som muligt.
English: Patients usually experience an improvement in lung function within 15 minutes of inhaling Revinty Ellipta.
Danish: Patienten oplever normalt en forbedring af lungefunktionen i løbet af 15 minutter efter inhalation af Revinty Ellipta.
English: There have been reports of increases in blood glucose levels in diabetic patients and this should be considered when prescribing to patients with a history of diabetes mellitus.
Danish: Der er rapporter om øget blodglucoseniveau hos diabetespatienter, og dette skal der tages hensyn til, når Revinty Ellipta udskrives til patienter med diabetes mellitus i anamnesen.
English: Cardiovascular effects, such as cardiac arrhythmias e.g. supraventricular tachycardia and extrasystoles may be seen with sympathomimetic medicinal products including Revinty Ellipta.
Danish: Der kan ses kardiovaskulære effekter, såsom hjertearytmier, f.eks. supraventrikulær takykardi og ekstrasystoli, med sympatomimetika, inklusive Revinty Ellipta.
English: 184/22, 85.7 in the FF/VI 92/22 and 42.3 in the VI 22 group.
Danish: for gruppen behandlet med FF/VI 184/22; 85,7 i FF/VI 92/22-gruppen og 42,3 i VI 22-gruppen.
English: Talk to your doctor before you use Revinty Ellipta: if you have liver disease, as you may be more likely to have side effects.
Danish: Kontakt lægen, før du tager Revinty Ellipta: - hvis du har en leversygdom, da det kan øge risikoen for bivirkninger.
English: Rinsing your mouth out with water immediately after using Revinty Ellipta may help stop this side effect developing.
Danish: Hvis du skyller munden med vand, og spytter vandet ud, umiddelbart efter, du har taget Revinty Ellipta, kan det være med til at forebygge, at du får denne bivirkning.
English: Pharmacotherapeutic group: Drugs for obstructive airways diseases, adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics, ATC code: R03AK10.
Danish: Farmakoterapeutisk klassifikation: Midler mod obstruktiv lungesygdom, adrenergika i kombination med kortikosteroider eller andre lægemidler, ex. antikolinergika.ATC-kode: R03AK10.
English: If patients are inadequately controlled on Revinty Ellipta 92/22 micrograms, the dose can be increased to 184/22 micrograms, which may provide additional improvement in asthma control.
Danish: Hvis patienten ikke er velkontrolleret på Revinty Ellipta 92/22 mikrogram, kan dosis øges til 184/22 mikrogram, der kan give en yderligere forbedring af astmakontrollen.
English: This leaflet was last revised in <{MM/YYYY}> Other sources of information
Danish: Denne indlægsseddel blev senest ændret <{MM/ÅÅÅÅ}>
English: Patients should be asked to continue treatment but to seek medical advice if asthma symptoms remain uncontrolled or worsen after initiation of treatment with Revinty Ellipta.
Danish: Patienterne skal informeres om at fortsætte behandlingen og søge læge, hvis astmasymptomerne ikke kan kontrolleres efter opstart af behandling med Revinty Ellipta, eller hvis de forværres.
English: If you have any of the following symptoms after taking Revinty Ellipta stop taking this medicine and tell your doctor immediately.
Danish: Hvis du oplever nogle af de følgende symptomer efter at have taget Revinty Ellipta, skal du stoppe med at tage medicinen og straks kontakte lægen.
English: Revinty Ellipta contains lactose
Danish: Revinty Ellipta indeholder lactose
English: if you think the above applies to you, don't use Revinty Ellipta until you have checked with your doctor.
Danish: Hvis du tror, at ovenstående gælder for dig, må du ikke tage Revinty Ellipta, før du har talt med lægen.
English: Fluticasone furoate or vilanterol has no or negligible influence on the ability to drive and use machines.
Danish: Fluticasonfuroat eller vilanterol påvirker ikke eller kun i ubetydelig grad evnen til at føre motorkøretøj og betjene maskiner.
English: Revinty Ellipta should not be used in conjunction with other long-acting beta2-adrenergic agonists or medicinal products containing longacting beta2-adrenergic agonists.
Danish: Revinty Ellipta bør ikke anvendes i kombination med andre langtidsvirkende beta2-agonister eller lægemidler, der indeholder langtidsvirkende beta2-agonister.
English: Revinty Ellipta contains two active substances: fluticasone furoate and vilanterol.
Danish: Revinty Ellipta indeholder to aktive stoffer: fluticasonfuroat og vilanterol.
English: Although there were more fractures in the Revinty Ellipta groups compared with the vilanterol 22 micrograms group, fractures typically associated with corticosteroid use (e.g., spinal compression/thoracolumbar vertebral fractures, hip and acetabular fractures) occurred in <1% of the Revinty Ellipta and vilanterol treatment arms.
Danish: Selvom der var flere frakturer i Revinty Ellipta-grupperne sammenlignet med gruppen, der fik vilanterol 22 mikrogram, var forekomsten af de frakturer, der typisk er forbundet med brug af kortikosteroider (f.eks. spinale kompressionsfrakturer/torakolumbale vertebrale frakturer, hofte- og hofteskålsfrakturer), <1 % i behandlingsarmene med Revinty Ellipta og vilanterol.
English: Revinty Ellipta is for inhalation use.
Danish: Revinty Ellipta er til inhalations brug.
English: In two replicate 12 month studies in a total of 3,255 patients with COPD the incidence of bone fractures overall was low in all treatment groups, with a higher incidence in all Revinty Ellipta groups (2%) compared with the vilanterol 22 micrograms group (<1%).
Danish: I to identiske 12-måneders studier med i alt 3.255 KOL-patienter var forekomsten af knoglefrakturer samlet set lav i alle behandlingsgrupper, men højere i alle Revinty Ellipta-grupper (2 %) sammenlignet med gruppen, der fik vilanterol 22 mikrogram (<1 %).
English: Revinty Ellipta should not be used to relieve a sudden attack of breathlessness or wheezing.
Danish: Revinty Ellipta kan ikke anvendes til lindring af pludselige anfald af åndenød eller hvæsende vejrtrækning.
English: Asthma Revinty Ellipta is indicated for the regular treatment of asthma in adults and adolescents aged 12 years and older where use of a combination medicinal product (long-acting beta2-agonist and inhaled corticosteroid) is appropriate:
Danish: Astma Revinty Ellipta er indiceret til behandling af astma hos voksne og unge på 12 år og derover, hvor behandling med et kombinationspræparat (langtidsvirkende beta2-agonist og inhalationssteroid) er hensigtsmæssig:
English: Revinty Ellipta has been shown to reduce flare-ups and symptoms of asthma.
Danish: Det er påvist, at Revinty Ellipta reducerer opblussen af og symptomer på astma.
English: The European Medicines Agency has deferred the obligation to submit the results of studies with Revinty Ellipta in one or more subsets of the paediatric population in asthma (see section 4.2 for information on paediatric use).
Danish: Det Europæiske Lægemiddelagentur har udsat forpligtelsen til at fremlægge resultaterne af studier med Revinty Ellipta i en eller flere undergrupper af den pædiatriske population med astma (se pkt.
English: Revinty Ellipta 184/22 micrograms is not indicated for patients with COPD.
Danish: Revinty Ellipta 184/22 mikrogram er ikke indiceret til patienter med KOL.
English: Don't use this medicine if you are breastfeeding unless your doctor tells you that you can.
Danish: Brug ikke dette lægemiddel, hvis du ammer, med mindre din læge siger, at du kan.
English: Revinty Ellipta is indicated for the symptomatic treatment of adults with COPD with a FEV1<70% predicted normal (post-bronchodilator) with an exacerbation history despite regular bronchodilator therapy.
Danish: Revinty Ellipta er indiceret til symptomatisk behandling af voksne med KOL med FEV1< 70 % af forventet (post-bronkodilatator) med tilbagevendende eksacerbationer, hvor fast behandling med bronkodilatator ikke er tilstrækkelig.
English: The higher strength of Revinty Ellipta (184 micrograms fluticasone furoate and 22 micrograms of vilanterol) is not suitable for the treatment of COPD.
Danish: Den høje styrke af Revinty Ellipta (184 mikrogram fluticasonfuroat og 22 mikrogram vilanterol) er ikke egnet til behandling af KOL.
English: All patients were required to have a smoking history of at least 10 pack years; a post-salbutamol FEV1/FVC ratio less than or equal to 0.70; post-salbutamol FEV1 less than or equal to 70% predicted and have a Modified Medical Research Council (mMRC) dyspnea score 2 (scale 0-4) at screening.
Danish: Alle patienter skulle have en rygeanamnese på mindst 10 pakkeår, en FEV1/FVC-ratio efter salbutamol under eller lig med 0,70, et FEV1 efter salbutamol under eller lig med 70 % af forventet værdi og en dyspnøscore ≥ 2 på Modified Medical Research Council (mMRC) dyspnea scale (skala 0-4) ved screening.
English: 4.3 Contraindications Hypersensitivity to the active substances or to any of the excipients listed in section 6.1.
Danish: 4.3 Kontraindikationer Overfølsomhed over for de aktive stoffer eller over for et eller flere af hjælpestofferne anført i pkt.
English: The maximum recommended dose is Revinty Ellipta 184/22 micrograms once daily.
Danish: Den anbefalede maksimale dosis er Revinty Ellipta 184/22 mikrogram én gang dagligt.
English: The European Medicines Agency has waived the obligation to submit the results of studies with Revinty Ellipta in all subsets of the paediatric population in COPD (see section 4.2 for information on paediatric use).
Danish: Det Europæiske Lægemiddelagentur har dispenseret fra kravet om at fremlægge resultaterne af studier med Revinty Ellipta i alle undergrupper af den pædiatriske population ved indikationen KOL (se pkt.
English: The safety and efficacy of Revinty Ellipta in children under 12 years of age has not yet been established in the indication for asthma.
Danish: Sikkerhed og virkning af Revinty Ellipta hos børn med astma under 12 år er endnu ikke klarlagt.
English: In a placebo-controlled study (SUMMIT) in subjects with moderate COPD (mean percent postbronchodilator screening FEV1 of 60%, SD 6%), and a history of, or an increased risk of cardiovascular disease, the incidence of pneumonia with FF/VI, FF, VI and placebo was: adverse events (6%, 5%, 4%, 5%); serious adverse events (3%, 4%, 3%, 3%); adjudicated on treatment deaths due to pneumonia (0.3%, 0.2%, 0.1%, 0.2%); the exposure adjusted rates (per 1000 treatment years) were: adverse events (39.5, 42.4, 27.7, 38.4); serious adverse events (22.4, 25.1, 16.4, 22.2); adjudicated on-treatment deaths due to pneumonia (1.8, 1.5, 0.9, 1.4) respectively.
Danish: I et placebokontrolleret studie (SUMMIT) hos personer med moderat KOL (procentvis gennemsnitlig postbronkodilatator screening FEV1 på 60 %, SD 6 %), og en fortid med, eller en forøget risiko for kardiovaskulær sygdom var incidensen af pneumoni med FF/VI, FF, VI og placebo henholdsvis: bivirkninger (6 %, 5 %, 4 %, 5 %); alvorlige bivirkninger (3 %, 4 %, 3 %, 3 %); dødsfald på grund af pneumoni under behandling (0,3 %, 0,2 %, 0,1 %, 0,2 %); forekomst justeret for eksponering (pr. 1000 behandlingsår) var henholdsvis: bivirkninger (39,5, 42,4, 27,7, 38,4); alvorlige bivirkninger (22,4, 25,1, 16,4, 22,2); dødsfald på grund af pneumoni under behandling (1,8, 1,5, 0,9, 1,4).
English: Revinty Ellipta should be discontinued immediately, the patient assessed and alternative therapy instituted if necessary.
Danish: Revinty Ellipta bør omgående seponeres og patienten vurderes.
English: In an integrated analysis of the two replicate one year studies in moderate to severe COPD (mean predicted post-bronchodilator screening FEV1 of 45%, standard deviation (SD) 13%) with an exacerbation in the preceding year (n = 3255), the number of pneumonia events per 1000 patient years was 97.9 with FF/VI
Danish: I en samlet analyse af to identiske 1-års studier med moderate til svære KOL-patienter (forventede middelværdi for post-bronkodilatator screening FEV1 på 45 %, standardafvigelse (SD) 13 %), som havde haft en eksacerbation i det foregående år (n=3.255) var antallet af pneumonitilfælde pr. 1.000 patientår 97,9
English: Prescribers should be aware that in patients with asthma, fluticasone furoate (FF) 100 micrograms once daily is approximately equivalent to fluticasone propionate (FP) 250 micrograms twice daily, while FF 200 micrograms once daily is approximately equivalent to FP 500 micrograms twice daily.
Danish: Lægen skal være opmærksom på, at hos patienter med astma er 100 mikrogram fluticasonfuroat (FF) én gang dagligt omtrent er ækvivalent med 250 mg fluticasonpropionat (FP) to gange dagligt, mens 200 mikrogram FF én gang dagligt omtrent er ækvivalent med 500 mikrogram FP to gange dagligt, hos patienter med astma.
English: *, ** See below ‘Description of selected adverse reactions' *Pneumonia (see section 4.4)
Danish: * ,** Se nedenfor 'Beskrivelse af udvalgte bivirkninger'
English: Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu
Danish: Du kan finde yderligere information om dette lægemiddel på Det Europæiske Lægemiddelagenturs hjemmeside: http://www.ema.europa.eu
English: What you need to know before you use Revinty Ellipta 3.
Danish: Det skal du vide, før du begynder at tage Revinty Ellipta 3.
English: One inhalation of Revinty Ellipta 92/22 micrograms once daily.
Danish: En inhalation af Revinty Ellipta 92/22 mikrogram én gang dagligt.
English: If your breathing or wheezing gets worse straight after using Revinty Ellipta, stop using it and get medical help immediately.
Danish: Hvis din vejrtrækning eller hvæsen bliver værre umiddelbart efter, at du har taget Revinty Ellipta, skal du stoppe med at tage medicinen og søge lægehjælp med det samme.
English: How to use Revinty Ellipta See ‘Step-by-step instructions' after section 6 of this leaflet for full information.
Danish: Sådan skal du tage Revinty Ellipta Du kan finde en udførlig beskrivelse i 'Brugervejledning' efter punkt 6 i denne indlægsseddel.
English: INFORMATION IN BRAILLE revinty ellipta 92:22
Danish: INFORMATION I BRAILLESKRIFT revinty ellipta 92:22
English: Revinty Ellipta 184/22 micrograms should be considered for adults and adolescents 12 years and over who require a higher dose of inhaled corticosteroid in combination with a long-acting beta2-agonist.
Danish: Revinty Ellipta 184/22 mikrogram bør overvejes hos voksne og unge på 12 og derover, der har brug for en højere dosis inhalationssteroid i kombination med en langtidsvirkende beta2-agonist.
English: What Revinty Ellipta contains - The active substances are fluticasone furoate and vilanterol.
Danish: Revinty Ellipta indeholder - Aktive stoffer: fluticasonfuroat og vilanterol.
English: INFORMATION IN BRAILLE revinty ellipta 184:22
Danish: INFORMATION I BRAILLESKRIFT revinty ellipta 184:22
English: If you forget to use Revinty Ellipta Do not take a double dose to make up for a forgotten dose.
Danish: Du må ikke tage en dobbeltdosis som erstatning for den glemte dosis.
English: Revinty Ellipta has been shown to reduce flare-ups of COPD symptoms.
Danish: Det er påvist, at Revinty Ellipta reducerer opblussen af KOL-symptomer.
English: Revinty Ellipta is for inhalation use only.
Danish: Revinty Ellipta er kun beregnet til inhalation.
English: If you are breast-feeding, check with your doctor before you use Revinty Ellipta.
Danish: Hvis du ammer, skal du kontakte din læge, inden du bruger Revinty Ellipta.
English: How to use Revinty Ellipta 4.
Danish: Sådan skal du tage Revinty Ellipta 4.
English: The “Discard by” date is 6 weeks from the date you opened the tray.
Danish: Datoen ”Kasseres senest” er 6 uger efter den dag, hvor bakken blev åbnet.
English: A starting dose of one inhalation of Revinty Ellipta 92/22 micrograms once daily should be considered for adults and adolescents 12 years and over who require a low to mid dose of inhaled corticosteroid in combination with a long-acting beta2-agonist.
Danish: En startdosis med en inhalation én gang dagligt af Revinty Ellipta 92/22 mikrogram kan overvejes hos voksne og unge på 12 år og derover, der har behov for en lav til middel dosis inhalationssteroid i kombination med en langtidsvirkende beta2-agonist.
English: What you need to know before you use Revinty Ellipta
Danish: Det skal du vide, før du begynder at tage Revinty Ellipta
English: Your Revinty Ellipta inhaler carton contains
Danish: Din æske med Revinty Ellipta-inhalator indeholder
English: If you are breast-feeding, you must check with your doctor before you use Revinty Ellipta.
Danish: Hvis du ammer, skal du tale med lægen, før du tager Revinty Ellipta.
English: 0.19 in the FF 92 micrograms group (approximately 1 in every 5 years) and 0.14 in the fluticasone furoate/vilanterol 92/22 micrograms group (approximately 1 in every 7 years).
Danish: Forekomsten af svære astma-eksacerbationer pr. patient pr. år var 0,19 i FF 92 mikrogram-gruppen (ca. 1 hvert 5. år) og 0,14 i gruppen med fluticasonfuroat/vilanterol 92/22 mikrogram (ca. 1 hvert 7. år).
English: Two different strengths of Revinty Ellipta are available: fluticasone furoate 92 micrograms/vilanterol 22 micrograms and fluticasone furoate 184 micrograms/vilanterol 22 micrograms.
Danish: Revinty Ellipta findes i to forskellige styrker: 92 mikrogram fluticasonfuroat og 22 mikrogram vilanterol eller 184 mikrogram fluticasonfuroat og 22 mikrogram vilanterol.
English: If you have moderate or severe liver disease, your doctor will limit your dose to the lower strength of Revinty Ellipta (92/22 micrograms once daily).
Danish: Hvis du har moderat eller alvorlig leversygdom, vil lægen muligvis ændre din dosis til den laveste styrke af Revinty Ellipta
English: If you do not have a quick-acting inhaler contact your doctor.
Danish: Kontakt din læge, hvis du ikke har en hurtigtvirkende inhalator.
English: - Contact your doctor if you experience blurred vision or other visual disturbances.
Danish: Mens du bruger Revinty Ellipta - Kontakt din læge hvis du oplever sløret syn eller andre synsforstyrrelser.
English: EU/1/14/929/004 EU/1/14/929/005
Danish: EU/1/14/929/001 EU/1/14/929/002 EU/1/14/929/003
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (SINGLE PACK) 184/22 micrograms
Danish: MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE YDRE KARTON (ENKELTPAKNINGER) 184/22 mikrogram
English: If you have been told by your doctor that you have an intolerance to some sugars, or to milk protein, contact to your doctor before using this medicine.
Danish: Kontakt lægen, før du tager denne medicin, hvis din læge har fortalt dig, at du ikke tåler visse sukkerarter eller mælkeprotein.
English: How to use Revinty Ellipta
Danish: Sådan skal du tage Revinty Ellipta
English: NAME OF THE MEDICINAL PRODUCT Revinty Ellipta 92 micrograms/22 micrograms inhalation powder, pre-dispensed
Danish: LÆGEMIDLETS NAVN Revinty Ellipta 92 mikrogram/22 mikrogram inhalationspulver, afdelt.
English: While you're using Revinty Ellipta
Danish: Hvis du har glemt at tage Revinty Ellipta
English: NAME OF THE MEDICINAL PRODUCT Revinty Ellipta 184 micrograms/22 micrograms inhalation powder, pre-dispensed
Danish: LÆGEMIDLETS NAVN Revinty Ellipta 184 mikrogram/22 mikrogram inhalationspulver, afdelt.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Revinty Ellipta 92 micrograms/22 micrograms inhalation powder fluticasone furoate/vilanterol
Danish: LÆGEMIDLETS NAVN, STYRKE OG/ELLER ADMINISTRATIONSVEJ(E) Revinty Ellipta 92 mikrogram/22 mikrogram inhalationspulver fluticasonfuroat/vilanterol
English: If you use more Revinty Ellipta than you should
Danish: Hvis du har taget for meget Revinty Ellipta
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Revinty Ellipta 184 micrograms/22 micrograms inhalation powder fluticasone furoate/vilanterol
Danish: LÆGEMIDLETS NAVN, STYRKE OG/ELLER ADMINISTRATIONSVEJ(E) Revinty Ellipta 184 mikrogram/22 mikrogram inhalationspulver fluticasonfuroat/vilanterol
English: What Revinty Ellipta looks like and contents of the pack The Ellipta device itself is a light grey inhaler with a yellow mouthpiece cover and a dose counter.
Danish: Ellipta-inhalatoren er en lysegrå inhalator med en gul beskyttelseshætte over mundstykket og en dosistæller.
English: NAME OF THE MEDICINAL PRODUCT Revinty Ellipta 92 micrograms/22 micrograms inhalation powder, pre-dispensed fluticasone furoate/vilanterol
Danish: Revinty Ellipta 92 mikrogram/22 mikrogram inhalationspulver, afdelt fluticasonfuroat/vilanterol
English: Tlf: + 45 36 35 91 00 dk-info@gsk.com
Danish: GlaxoSmithKline Pharma A/S Tlf: + 45 36 35 91 00 dk-info@gsk.com
English: Revinty Ellipta 92 micrograms/22 micrograms inhalation powder, pre-dispensed Revinty Ellipta 184 micrograms/22 micrograms inhalation powder, pre-dispensed
Danish: Indlægsseddel: Information til brugeren Revinty Ellipta 92 mikrogram/22 mikrogram inhalationspulver, afdelt Revinty Ellipta 184 mikrogram/22 mikrogram inhalationspulver, afdelt fluticasonfuroat/vilanterol
English: NAME OF THE MEDICINAL PRODUCT Revinty Ellipta 184 micrograms/22 micrograms inhalation powder, pre-dispensed fluticasone furoate /vilanterol
Danish: Revinty Ellipta 184 mikrogram/22 mikrogram inhalationspulver, afdelt fluticasonfuroat/vilanterol
English: if you have tuberculosis (TB) of the lung, or any long standing or untreated infections.
Danish: (92/22 mikrogram én gang daglig) - hvis du har hjerteproblemer eller forhøjet blodtryk - hvis du har lungetuberkulose eller en anden langvarig eller ubehandlet infektion.
English: MARKETING AUTHORISATION NUMBER(S) EU/1/14/929/006
Danish: MARKEDSFØRINGSTILLADELSESNUMMER (-NUMRE) EU/1/14/929/006
English: MARKETING AUTHORISATION NUMBER(S) EU/1/14/929/001
Danish: MARKEDSFØRINGSTILLADELSESNUMMER (-NUMRE) EU/1/14/929/001
English: MARKETING AUTHORISATION NUMBER(S) EU/1/14/929/003
Danish: MARKEDSFØRINGSTILLADELSESNUMMER (-NUMRE) EU/1/14/929/003
English: MARKETING AUTHORISATION NUMBER(S) EU/1/14/929/004
Danish: MARKEDSFØRINGSTILLADELSESNUMMER (-NUMRE) EU/1/14/929/004
English: if you have ever been told you have diabetes or high blood sugar.
Danish: - hvis du på noget tidspunkt har fået konstateret diabetes eller højt blodsukker - hvis du har problemer med skjoldbruskkirtlen - hvis du har lavt kaliumindhold i blodet - hvis du oplever sløret syn eller andre synsforstyrrelser.
English: - if you are pregnant.
Danish: - Hvis De er gravid.
English: It may harm them, even if their symptoms are the same as yours.
Danish: Det kan skade dem, også selvom deres symptomer er de samme som Deres egne.
English: - if you had a heart attack less than a month ago.
Danish: - Hvis De har haft et hjerteanfald for mindre end en måned siden.
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION 29 November 2004
Danish: DATO FOR DEN FØRSTE TILLADELSE/FORNYELSE AF TILLADELSEN 29. november 2004
English: Considering the design of the study, no conclusions can be drawn from the results of the separate analysis.
Danish: I betragtning af undersøgelsens design, kan der ikke trækkes konklusioner ud af resultaterne af den separate analyse.
English: You may need to read it again.
Danish: Du kan få brug for den igen.
English: - if you use a stoma.
Danish: - Hvis De bruger en stoma.
English: You may not use this medicine in such a case.
Danish: De må ikke anvende dette lægemiddel i sådan et tilfælde.
English: The following side effects can occur:
Danish: Følgende bivirkninger kan forekomme:
English: Do not take a double dose to make up for a forgotten tablet.
Danish: Tag ikke dobbeltdosis for at indhente en glemt tablet.
English: Other types of interactions
Danish: Andre typer interaktioner
English: Caution should be taken when both medicines are used in combination.
Danish: Der bør udvises forsigtighed, når begge medikamenter bruges i kombination med hinanden.